The close relationship between joints and gut inflammation has long been known and several data suggest that dysbiosis could link spondyloarthritis (SpA) to inflammatory bowel diseases (IBD). The introduction of biological drugs, in particular tumour necrosis factor inhibitors (TNFi), revolutionised the management of both these diseases. While the impact of conventional drugs on gut microbiota is well known, poor data are available about TNFi.
Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis
Borrelli, Richard;Realmuto, Cristina;Caviglia, Gian Paolo;Ribaldone, Davide Giuseppe;Astegiano, Marco;
2021-01-01
Abstract
The close relationship between joints and gut inflammation has long been known and several data suggest that dysbiosis could link spondyloarthritis (SpA) to inflammatory bowel diseases (IBD). The introduction of biological drugs, in particular tumour necrosis factor inhibitors (TNFi), revolutionised the management of both these diseases. While the impact of conventional drugs on gut microbiota is well known, poor data are available about TNFi.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
e001755.full.pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
851.75 kB
Formato
Adobe PDF
|
851.75 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
